CONNECT. COLLABORATE. CATALYZE.
Bringing the Life Sciences’ Industry Together to Innovate for Advancement of Health Around the World
×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Regulatory Roundup: Insights from Global Town Halls at DIA 2024
Representation included intergovernmental bodies (WHO), international coalitions (ICMRA), and regional agencies including the US FDA, EMA, Health Canada, ANVISA, PMDA, and NMPA.
Global CTD and Data Transparency Conference
Enhance trial transparency, navigate regulatory changes, and explore AI-driven practices while expanding your network across other clinical and regulatory life science professionals.
播客
DIA: Going Beyond the Traditional Definition of Drug Development
In this DIA 60th anniversary interview, former Board President Ling Su shares the two most important aspects of DIA’s future for the next generation of members.
全球论坛，DIA数字杂志
聚焦会员
-
people_outlineLearn MoreCasey Walker
“我阿姨的一些病人是滥用药物的受害者，看到她照顾他们，激励了我寻找治疗这些患者的方法，并选择以药学为职业。”Doctor of Pharmacy Candidate, Howard University
-
people_outlineLearn MoreJingsong Wang
“我们仍有很多未满足的医疗和患者需求，只有当社区(包括研究人员、医生和政策制定者)共同努力才能解决。近年来这种情况越来越多，可以在当今一些最先进的药物和医疗保健系统中看到其结果。”CEO, Harbour BioMed
-
people_outlineLearn MoreKim Quaintance-Lunn
“在我看来，最大的挑战是全球卫生当局之间缺乏协调。我们不应该为了协调而协调，而应该协调到最好的做法。”Vice President and Head, Regulatory Policy, North American Regulatory Affairs, Bayer
“我阿姨的一些病人是滥用药物的受害者，看到她照顾他们，激励了我寻找治疗这些患者的方法，并选择以药学为职业。”